1136PD - Quality of Life (Qol) with Lanreotide Autogel (Lan) Vs. Placebo in Patients with Enteropancreatic Neuroendocrine Tumours (Ep-Nets): Results from the Clarinet Phase III Study
| Autor: | Ruszniewski, P., Caplin, M., Pavel, M., Ćwikła, J., Phan, A., Raderer, M., Sedlackova, E., Cadiot, G., Wall, L., Rindi, G., Langley, A., Blumberg, J., Gomez-Panzani, E. |
|---|---|
| Zdroj: | In Annals of Oncology September 2014 25 Supplement 4:iv396-iv396 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|